drugset
drugset / Trial / NCT02304770

Aminolaevulinic Acid Photodynamic Therapy of Cervical Persistent HPV Infection and Cervical Neoplasia

NCT02304770 ↗

Phase 2 Completed 73 enrolled Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The study will examine the effect of aminolaevulinic acid (ALA) photodynamic therapy (PDT) of cervical precancerous lesions in women.

Timeline

Start
2015-01
Primary completion
2017-01
Completion
2017-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Aminolaevulinic acid Unknown — —

Indications

cervical intraepithelial neoplasia human papilloma virus infection